Aquestive Therapeutics (AQST)
(Real Time Quote from BATS)
$3.99 USD
+0.13 (3.37%)
Updated Aug 15, 2024 09:38 AM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Brokerage Reports
Aquestive Therapeutics, Inc. [AQST]
Reports for Purchase
Showing records 61 - 80 ( 403 total )
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
FDA Grants Libervant Tentative Approval; Focus Remains on AQST-109
Provider: Wedbush Securities Inc.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Management and Board Additions; 2Q22 Financials; Raising PT to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Wedbush Healthcare Conference - That''s A Wrap; Key Takeaways
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Q2: EPIPHAST II Data in Q3; Delay Continues for Potential Libervant Approval
Provider: Wedbush Securities Inc.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Final EPIPHAST Data Provides Positive Surprise; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Results from Final Two Arms of Part 3 of EPIPHAST; EPIPHAST II Study Underway
Provider: Wedbush Securities Inc.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Results From Final Two Arms of Part 3 of EPIPHAST; EPIPHAST II Study Underway
Provider: Wedbush Securities Inc.
Analyst: MOUSSATOS L